Inactive

This notice is a Notice of Intent. (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed con... This notice is a Notice of Intent. (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a Sole Source Firm-Fixed Price Contract under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) – Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive quotes. The National Institute of Allergy and Infectious Diseases (NIAID), NIH Clinical Center, intends to award a firm-fixed price sole source contract to Somalogic, 2945 Wilderness Place, Boulder, CO 80301 The National Institute of Allergy and Infectious Diseases (NIAID), Center for Human Immunology (CHI) intends to negotiate on an other than full and open competition basis with SomaLogic, 2945 Wilderness Place Boulder, CO 80301 for: SomaScan 7K Assay kits (Kit, SomaScan 11K Assay - Human Plasma (900-00050) or Serum (900-00051) Qty: 7 Shipping cost FOB Destinations TO BETHESDA, MD 20814 with a POP 01/01/2024 – 12/31/2024 This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a)(1). Only one award will be made. This will be awarded as a firm fixed price type of contract. SomaLogic, SOMAscan Kits can only be provided by one source. 20 Domestic Shipping and Handling – FOB DESTINATION TO BETHESDA, MD 20814 The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2201004) to Diana Rohlman at diana.rohlman@nih.gov, by 4:00 pm eastern standard time, December 9, 2023. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. .